Stock speculation to see Jin Kirin analyst research report, authoritative, professional, timely, comprehensive, to help you tap the potential of the theme opportunity!
At 11:29 in the morning trading on April 30, 2024, Zhiyun Health (09955Gyrigalagames.HK) the stock fluctuated and the share price quickly rose by 5.10%. As of press time, the stock was reported at 3.091 Hong Kong dollars per share, with a turnover of 9.9158 million shares, a turnover rate of 1.69% and an amplitude of 6.80%.
On the capital side, the stock has an inflow of HK $10.9902 million and an outflow of HK $11.7838 million.
The most recent results show that the stock achieved operating income of HK $4.072 billion, net profit of-HK $356 million, earnings per share of-HK $0.66, gross profit of HK $1.003 billion, and price-earnings ratio of-5.09 times.
In terms of agency rating, of all the two agencies that participated in the rating, 50% of the brokerages gave buying advice, 50% of the brokerages gave holding advice, and no brokerage gave selling advice.
Zhiyun Health shares in the medical equipment and supplies industry, the overall increase of 0.005%. Among its related stocks, Kaisa Health, Junbaiyan Group and Zhiyun Health increased significantly, and the related stocks with larger amplitudes were Kaisa Health, China Inspection Medical and GUANZE MEDICAL, with amplitudes of 38.10%, 18.83% and 9.09%, respectively.
Introduction of Zhiyun Health Co., Ltd.GyrigalagamesZhiyun Health Technology Group is a Chinese holding company mainly engaged in providing medical services and products. The company provides medical supplies and software-as-a-service (SaaS) products for hospitals and pharmacies, digital marketing services for pharmaceutical companies, and online consultation and prescription for patients. The company's product portfolio consists of three major product or service categories. In-hospital solutions mainly include hospital medical supplies, hospital SaaS and digital marketing services. Drugstore solutions mainly include drugstore supplies and drugstore SaaS. Personal chronic disease management solutions and others mainly include chronic disease products, membership services, as well as insurance brokerage services, advertising agency services and others.
(the above content is Portfolio based on public information, intelligently generated by programs or algorithms, only as a reference for users to view the market, not as investment advice or transaction basis. The stock market is risky, please make a careful decision. )